Application of Machine Learning for Predicting Progression‐Free and Overall Survival in Patients With Renal Cell Carcinoma
ABSTRACT Patient outcomes in advanced renal cell carcinoma (RCC) remain poor, with five‐year survival rates ranging from ~10% to 30%. Early projections of therapeutic outcomes could optimize precision medicine and accelerate drug development. While machine learning (ML) models integrating tumor grow...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2025-10-01
|
| Schriftenreihe: | Clinical and Translational Science |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1111/cts.70348 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
